Agencies

Globally, the World Health Organisation (WHO) is tracking around 140 candidates vaccines, of which around two dozen are in various phases of human clinical trials.

The world is eagerly waiting for a vaccine to combat the coronavirus which has ravaged through the world resulting in more than six lakh deaths.

There was buzz in the medical fraternity after the editor of medical journal The Lancet announced on Twitter that he is going to announce the results of the Oxford Covid-19 vaccine study.

�Tomorrow. Vaccines. Just saying,� Richard Horton tweeted on Sunday.

Globally, the World Health Organisation (WHO) is tracking around 140 candidates vaccines, of which around two dozen are in various phases of human clinical trials.

Chinese company Sinovac Biotech is moving into phase III trials in Brazil while University of Oxford/AstraZeneca is in a combine phase II/III trial in the UK and has recently gone into phase III trials in South Africa and Brazil.

Among other leading players, German firm BioNTech is collaborating with pharma major Pfizer to develop a vaccine for Covid-19. The companies have received fast track designation from the US Food and Drug Administration (USFDA) for two investigational vaccine candidates being developed to help protect against SarS-CoV-2.